BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clinic Proceedings 2019;94:714-26. [DOI: 10.1016/j.mayocp.2018.12.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Hu Y, Wen Z. Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy. Sci Rep 2021;11:150. [PMID: 33420233 DOI: 10.1038/s41598-020-80136-0] [Reference Citation Analysis]
2 Kim J, Randhawa H, Sands D, Lambe S, Puglia M, Serrano PE, Pinthus JH. Muscle-Invasive Bladder Cancer in Patients with Liver Cirrhosis: A Review of Pertinent Considerations. BLC 2021;7:261-78. [DOI: 10.3233/blc-211536] [Reference Citation Analysis]
3 Zhou H, Hu H, Tian M, Chu J, Tian C, Yang Y, Lin S. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterol Res Pract 2020;2020:4217512. [PMID: 33376483 DOI: 10.1155/2020/4217512] [Reference Citation Analysis]
4 Marwa Gamaleldin A, Walid Ellakany I, Marwa Saad A, Reham Aboelwafa A. Serum serotonin as a non-invasive marker of portal hypertensive gastropathy in Egyptian patients with HCV-related liver cirrhosis. Acta Gastroenterol Belg 2022;85:73-9. [PMID: 35304996 DOI: 10.51821/85.1.9023] [Reference Citation Analysis]
5 Fiel MI, Schiano TD. Idiopathic noncirrhotic portal hypertension. Seminars in Diagnostic Pathology 2019;36:395-403. [DOI: 10.1053/j.semdp.2019.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
6 Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun 2021. [PMID: 34904404 DOI: 10.1002/hep4.1855] [Reference Citation Analysis]
7 Ye J, Wang L, Lu S, Yang D, Hu W, Lu H, Zhang Y. Clinical study on cystogastrostomy and Roux-en-Y-type cystojejunostomy in the treatment of pancreatic pseudocyst: A single-center experience. Medicine (Baltimore) 2021;100:e25029. [PMID: 33725885 DOI: 10.1097/MD.0000000000025029] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Navin PJ, Gidener T, Allen AM, Yin M, Takahashi N, Torbenson MS, Kamath PS, Ehman RL, Venkatesh SK. The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol 2020;18:3051-3053.e2. [PMID: 31629882 DOI: 10.1016/j.cgh.2019.10.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Rodriguez EA, Perez R, Zhang N, Lim ES, Miller C, Schwartz MA, McGirr AJ, Srinivasan A, Hewitt W, Silva AC, Rakela J, Vargas HE. Clinical Outcomes of Portosystemic Shunts on the Short-Term Outcome of Liver Transplantation. Liver Transpl. 2019;. [PMID: 31872966 DOI: 10.1002/lt.25710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
10 Liu H, Liu J. Improved support vector machine algorithm based on the influence of Gestational Diabetes Mellitus on the outcome of perinatal outcome by ultrasound imaging. Pak J Med Sci 2021;37:1625-9. [PMID: 34712295 DOI: 10.12669/pjms.37.6-WIT.4855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kristensen H, Kimer N, Møller S. Indications and methods for measuring portal hypertension in cirrhosis. Scand J Gastroenterol 2022;:1-9. [PMID: 35514215 DOI: 10.1080/00365521.2022.2065889] [Reference Citation Analysis]
12 Zhou LL, Wang GC, Zhang MY, Huang GJ, Li W, Wang LY, Wang AH, Zhang CQ. Nomogram for hepatic venous pressure gradient in patients with cirrhosis. J Dig Dis 2021;22:488-95. [PMID: 34272920 DOI: 10.1111/1751-2980.13033] [Reference Citation Analysis]
13 Ezhilarasan D. Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells. Exp Biol Med (Maywood) 2020;245:1504-12. [PMID: 32791849 DOI: 10.1177/1535370220949148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Souto EO. Endoscopic Ultrasound Evaluation of Portal Pressure. Clin Liver Dis 2022;26:e1-e10. [PMID: 34802666 DOI: 10.1016/j.cld.2021.10.001] [Reference Citation Analysis]
15 Manguso G, Vignone A, Merli M, Miotti C, Caputo A, Vizza CD, Badagliacca R. Hemodynamic Evaluation of the Right Heart-Pulmonary Circulation Unit in Patients Candidate to Transjugular Intrahepatic Portosystemic Shunt. JCM 2022;11:461. [DOI: 10.3390/jcm11020461] [Reference Citation Analysis]
16 Tai Y, Zhao C, Zhang L, Tang S, Jia X, Tong H, Liu R, Tang C, Gao J. Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress. J Cell Mol Med 2021;25:10389-402. [PMID: 34609050 DOI: 10.1111/jcmm.16968] [Reference Citation Analysis]
17 Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Babb J, Shanbhogue KP. MR elastography, T1 and T2 relaxometry of liver: role in noninvasive assessment of liver function and portal hypertension. Abdom Radiol (NY) 2020;45:2680-7. [PMID: 32274552 DOI: 10.1007/s00261-020-02432-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
18 Wang JC, Pan Y, Chen J, Hu D, Tuoheti Y, Zhou Z, Xu L, Chen J, Chen M, Zhang Y. Single versus multiple port laparoscopic left lateral sectionectomy for hepatocellular carcinoma: A retrospective comparative study. Int J Surg 2020;77:15-21. [PMID: 32179178 DOI: 10.1016/j.ijsu.2020.03.003] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sabrina V, Michael B, Jörg A, Peter B, Wolf B, Susanne B, Thomas B, Frank D, Matthias E, Markus F, Christian F, Paul F, Andreas G, Eleni G, Martin G, Elke H, Thomas H, Ralf-Thorsten H, Wolf-Peter H, Peter H, Achim K, Gabi K, Jürgen K, David K, Frank L, Hauke L, Thomas L, Philipp L, Andreas M, Alexander M, Oliver M, Silvio N, Huu Phuc N, Johann O, Karl-Jürgen O, Philipp P, Kerstin P, Philippe P, Thorsten P, Mathias P, Ruben P, Jürgen P, Jutta R, Peter R, Johanna R, Ulrike R, Elke R, Barbara S, Peter S, Irene S, Andreas S, Dietrich VS, Daniel S, Marianne S, Alexander S, Andreas S, Nadine S, Christian S, Andrea T, Anne T, Jörg T, Ingo VT, Reina T, Arndt V, Thomas V, Hilke V, Frank W, Oliver W, Heiner W, Henning W, Dane W, Christian W, Marcus-Alexander W, Peter G, Nisar M. S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms. Z Gastroenterol 2022;60:e56-e130. [PMID: 35042248 DOI: 10.1055/a-1589-7568] [Reference Citation Analysis]
20 Leung M, Humphrey ML, Chen LX, Sarkar S. Ascites development is associated with worse outcome in patients after kidney transplantation. Clin Transplant 2021;35:e14198. [PMID: 33345373 DOI: 10.1111/ctr.14198] [Reference Citation Analysis]
21 Rong YM, Zhang HW, Zhang JH, Liu P, Gao HD. Prediction model of high risk esophageal and gastric varices in patients with compensated hepatitis B cirrhosis: A case-control study. Shijie Huaren Xiaohua Zazhi 2022; 30(3): 152-157 [DOI: 10.11569/wcjd.v30.i3.152] [Reference Citation Analysis]
22 Zhang W, Peng C, Zhang S, Huang S, Shen S, Xu G, Zhang F, Xiao J, Zhang M, Zhuge Y, Wang L, Zou X, Lv Y. EUS-guided portal pressure gradient measurement in patients with acute or subacute portal hypertension. Gastrointest Endosc 2021;93:565-72. [PMID: 32615178 DOI: 10.1016/j.gie.2020.06.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Yang Y, Fu S, Cao B, Hao K, Li Y, Huang J, Shi W, Duan C, Bai X, Tang K, Yang S, He X, Lu L. Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study. Hepatol Int 2021;15:730-40. [PMID: 33977364 DOI: 10.1007/s12072-021-10188-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Dos Santos Pinheiro C, de Oliveira Gomes CG, Ribeiro Lima Machado C, Guedes LR, Rocha HC, Guimarães RG, Carvalho FAC, Saturnino SF, do Nascimento VC, de Andrade MVM, Vilela EG. Performance of High Mobility Protein Group 1 and Interleukin-6 as Predictors of Outcomes Resulting from Variceal Bleeding in Patients with Advanced Chronic Liver Disease. Inflammation 2021. [PMID: 34618276 DOI: 10.1007/s10753-021-01565-1] [Reference Citation Analysis]
25 Chandna S, Zarate ER, Gallegos-Orozco JF. Management of Decompensated Cirrhosis and Associated Syndromes. Surg Clin North Am 2022;102:117-37. [PMID: 34800381 DOI: 10.1016/j.suc.2021.09.005] [Reference Citation Analysis]
26 Baiges A, Hernández-Gea V. Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding. Clin Drug Investig 2022. [PMID: 35476218 DOI: 10.1007/s40261-022-01147-5] [Reference Citation Analysis]
27 Rittig N, Aagaard NK, Villadsen GE, Sandahl TD, Jessen N, Grønbaek H, George J. Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension. Aliment Pharmacol Ther 2021;54:320-8. [PMID: 34165199 DOI: 10.1111/apt.16460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Metwally K, Essam T, Atwa A, Awad S, Abdelsameea E. Helicobacter pylori versus Platelet-to-Spleen Ratio as a Risk Factor for Variceal Bleeding in Patients with Liver-Cirrhosis-Related Portal Hypertension. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.10.018] [Reference Citation Analysis]